O'Shaughnessy Asset Management’s Axsome Therapeutics AXSM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Buy	2,073 +503	+32%	+$109K	﹤0.01%	1595
2026 Q1	$265K	Sell	1,570 -800	-34%	-$138K	﹤0.01%	1843
2025 Q4	$433K	Buy	2,370 +40	+2%	+$5.58K	﹤0.01%	1574
2025 Q3	$283K	Buy	+2,330	New	+$262K	﹤0.01%	1780
2025 Q2	–	Sell	-3,104	Closed	-$362K	–	2385
2025 Q1	$362K	Buy	+3,104	New	+$354K	﹤0.01%	1476
2021 Q4	–	Sell	-1,336	Closed	-$44K	–	1356
2021 Q3	$44K	Hold	1,336	–	–	﹤0.01%	1689
2021 Q2	$90K	Buy	+1,336	New	+$80.2K	﹤0.01%	1347

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

O'Shaughnessy Asset Management's AXSM Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Axsome Therapeutics (AXSM) stake by 32% in Q2 2026, buying an estimated $109K and bringing the position to 2,073 shares worth $507K. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

O'Shaughnessy Asset Management first reported a position in AXSM in Q2 2021 and has held it in 7 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

O'Shaughnessy Asset Management held 2,073 shares of Axsome Therapeutics worth $507K as of Q2 2026.
O'Shaughnessy Asset Management bought 503 Axsome Therapeutics shares in Q2 2026, an estimated $109K.
Axsome Therapeutics made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1595 holding.
O'Shaughnessy Asset Management first reported a position in Axsome Therapeutics in Q2 2021 and has held it in 7 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.